Eugene Somoza, M.D.
Studies associated with:
| Division | Study Number | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| DTMC | NIDA-CTO-0012 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Tiagabine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | |
| DTMC | NIDA-CTO-0001 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | |
| CTN | NIDA-CTN-0046 | Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes | T. John Winhusen, Ph.D., Eugene Somoza, M.D. | |
| CTN | NIDA-CTN-0031A | An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers | T. John Winhusen, Ph.D., Eugene Somoza, M.D. | |
| CTN | NIDA-CTN-0029 | A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD | T. John Winhusen, Ph.D., Eugene Somoza, M.D. | |
| DTMC | NIDA-CPU-0016 | Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Methamphetamine And Osmotic-Release Methylphenidate (Oros-Mph) | Eugene Somoza, M.D. |